|
Originally published In Press as doi:10.1074/jbc.M104202200 on August 20, 2001
J. Biol. Chem., Vol. 276, Issue 46, 43239-43245, November 16, 2001
A Molecular Switch for Specific Stimulation of the
BKCa Channel by cGMP and cAMP Kinase*
Xiao-Bo
Zhou ,
Claudia
Arntz§¶,
Simone
Kamm§¶,
Karin
Motejlek ,
Ulrike
Sausbier§,
Ge-Xin
Wang ,
Peter
Ruth§ , and
Michael
Korth
From the Abteilung Pharmakologie für
Pharmazeuten, Universitätsklinikum Hamburg-Eppendorf, Martinistr.
52, D-20246 Hamburg and § Institut für
Pharmakologie und Toxikologie der Technischen Universität
München, Biedersteinerstr. 29, D-80802 München Germany
Received for publication, May 9, 2001, and in revised form, August 2, 2001
 |
ABSTRACT |
The cGMP and the cAMP pathways control smooth
muscle tone by regulation of BKCa (BK) channel
activity. BK channels show considerable diversity and plasticity in
their regulation by cyclic nucleotide-dependent protein
kinases. The underlying molecular mechanisms are unclear but may
involve expression of splice variants of the BK channel subunit.
Three isoforms, BKA, BKB, and BKC,
which were cloned from tracheal smooth muscle, differed only in their C
terminus. When expressed in HEK293 cells, cGMP kinase (cGK) but not
cAMP kinase (cAK) stimulated the activity of BKA and
BKB by shifting the voltage dependence of the channel to
more negative potentials. In contrast, BKC was exclusively
stimulated by cAK. BKC lacks a C-terminal tandem
phosphorylation motif for protein kinase C (PKC) with
Ser1151 and Ser1154. Mutation of this motif in
BKA switched channel regulation from cGK to cAK.
Furthermore, inhibition of PKC in excised patches from cells expressing
BKA abolished the stimulatory effect of cGK but allowed
channel stimulation by cAK. cAK and cGK phosphorylated the channel at
different sites. Thus, phosphorylation/dephosphorylation by PKC
determines whether the BK channel is stimulated by cGK or cAK. The
molecular mechanisms may be relevant for smooth muscle relaxation by
cAMP and cGMP.
 |
INTRODUCTION |
The cGMP and the cAMP pathways are major regulators of smooth
muscle contractility (1). It is widely accepted that activation of
large conductance Ca2+-activated K+ (BK)
channels via cGMP kinase
(cGK)1 (2, 3) and cAMP kinase
(cAK) (4, 5) contributes to relaxation (6). However, the responses of
BK channels to hormones and drugs that activate either the cAMP or the
cGMP-signaling pathway vary from tissue to tissue (7-10) and even
within the same tissue (11, 12). Alternatively, spliced mRNA
transcripts and reversible protein phosphorylation of the BK channel
subunit or closely associated proteins have been shown as major
mechanisms for the diversity of channel regulation by protein kinases
(13). Particularly, the large C-terminal domain of the BK channel subunit has been suggested as the target for phosphorylation by several
serine/threonine-directed kinases (14). The molecular requirements at
the BK channel level, however, that are necessary for modulation by
specific cyclic nucleotide-dependent protein kinases have
not yet been resolved. Recently, phosphorylation sites for cAK (15) and
cGK (16, 17) have been identified that may be important for specific BK
channel activation. Since these sites are fully conserved in all
mammalian alternative splice variants known so far, regulation of BK
channels via both the cGK and cAK would be expected. However, in most
reports on cyclic nucleotide-dependent channel stimulation,
effects from either cGK (3, 16-19) or cAK (13, 15, 20, 21) have been
described. In particular, it is not clear whether cGK and cAK can
substitute for each other as channel regulators, whether they have
additive effects, or whether specific requirements are needed that
allow distinct regulation by either kinase. The elucidation of
molecular mechanisms underlying BK channel regulation is even more
complicated by the fact that BK channels apart from cGK and cAK are
presumably modulated by additional protein kinases such as PKC (22) and Src (21). These protein kinases may interact with each other in
modifying channel activity. Thus, BK channels seem to integrate the
output from several signaling cascades.
With respect to channel regulation by protein kinases, it has been an
important issue in recent years to identify the underlying molecular
mechanisms (13, 15-19, 21, 23). In this study, we first analyzed
whether distinct mRNA transcripts in tracheal smooth muscle
represent the molecular basis for differential regulation of BK channel
by cAK and cGK. We identified three C-terminal isoforms of the BK
channel subunit that are presumably generated by alternative splicing at cryptic intron sites within a C-terminal exon. All of the
isoforms showed similar single channel conductance and Ca2+
sensitivity. The presence of the C-terminal tandem phosphorylation site
for PKC in two isoforms allowed stimulation of channel activity by cGK,
suggesting the involvement of PKC in cGK-dependent channel regulation. However, the absence of this motif in another splice variant resulted in a loss of stimulation via cGK but led to activation by cAK. The hypothesis of phosphorylation by PKC as a prerequisite for
the stimulatory effect of cGK was proved by mutation of respective serines and the use of specific PKC inhibitors. The results suggest that constitutive phosphorylation by PKC at the C terminus allows conditional activation by cGK. In turn, stimulation by cAK occurs at
the dephosphorylated channel and at splice variants lacking the
C-terminal PKC motif. The mechanisms identified here may contribute to
the relaxation induced by NO and 2-adrenoreceptor
agonists in smooth muscle.
 |
MATERIALS AND METHODS |
Cloning--
BK channel subunits were cloned from a bovine
tracheal smooth muscle oligo dT-primed cDNA library. About 800,000 clones of the library were screened with the
EcoRV/HaeII fragment corresponding to the region
between the S0 and S6 segment. The probe (nucleotides 400-989) was
isolated from the human BK channel subunit cDNA, kindly
provided by Dr. L. Toro (GenBankTM U11058) (24). Isolated
full-length clones were sequenced and constructed into the expression
vector pcDNA3 (Invitrogen), which directed expression of BK channel
subunits in HEK293 cells starting translation from the M1
methionine (24). The GenBankTM accession numbers for the BK
channel isoforms are AY033472 (BKA), AY033473
(BKB), AY033474 (BKC).
Site-directed Mutagenesis--
Mutants were generated by
extended overlap polymerase chain reaction using the primer pairs as
indicated. The resulting amplicons were digested with the given
restriction enzymes and cloned into pcDNA3 containing the
respective isoform of the BK channel. All mutations were confirmed by
sequence analysis. Primer sequences are as follows (mutated bases in
bold letters): BKA S1151A, M1/SP6, F8/M2, template
BKA, ApaI; BKA S1154A,
M3/SP6, F8/M4, template BKA, ApaI;
BKA S1151A/S1154A, M5/SP6, F8/M6, template BKA,
ApaI; BKA S1134A, M7/SP6, F8/M8, template
BKA, ApaI; BKC S1134A, M7/SP6, F8/M8, template BKC, ApaI; BKA
S1134A/S1151A/S1154A, M7/SP6, F8/M8, template BKA
S1151A/S1154A, ApaI; BKA S922A/S1151A/S1154A,
M9/R12, F6/M10, template BKA S1151A/S1154A,
AflII and SacII. Forward primers are: F6
(GAAACCATCTTAAGATCCAA); F8 (GCAGCCGTTTGCATGTGGGA); M1 (AAG
GCCCGGGAGTCCCGAGACAAACAGAAGTAC); M3
(AAGTCCCGGGAGGCCCGAGACAAACAGAAGTAC); M5
(AAGGCCCGGGAGGCCCGAGACAAACAGAAGTAC); M7
(AAGAGCGCCTCCGTCCACTCCATCCCA); M9
(AGCCCGCCATCACTACTGGGGTCAACATCCCCATC). Reverse primers are:
SP6 (from pcDNA3) (ATTTAGGTGACACTATAGAACTC); R12
(GATGGAGTGGACGGAGGAGCTC); M2
(GGACTCCCGGGCCTTGGGCCGGTTCTGTCGG); M4
(GGCCTCCCGGGACTTGGGCCGGTTCTGTCGG); M6
(GGCCTCCCGGGCCTTGGGCCGGTTCTGTCGG); M8
(GACGGAGGCGCTCTTCTTGCTAGAGGACTG); M10
(AGTAGTGATGGCGGGCTGGCGTAACATCCCATG).
Functional Expression in HEK293 Cells and Electrophysiological
Measurements--
HEK293 cells were transfected with the channel
cDNA plasmids by calcium phosphate precipitation for 18 h at
35 °C and 3% CO2. The transfection efficiency varied
between 40 and 70%. Macroscopic currents were recorded 48 h after
transfection from inside-out patches excised from HEK293 cells by using
a List EPC 7 amplifier connected via a 16-bit analog-to-digital
interface to a Pentium IBM clone computer (25). Signals were filtered
at 1 kHz by a 10-pole Bessel filter and sampled at 3 kHz. Data
acquisition and analysis was performed with an ISO-3 patch-clamp
program (MFK, Niedernhausen, Germany). The patch pipettes were pulled
from borosilicate glass (fiber-filled) with a resistance of 3-4
megaohms and were filled with physiological saline solution containing
127 mM NaCl, 5.9 mM KCl, 2.4 mM
CaCl2, 1.2 mM MgCl2, 11 mM glucose, and 10 mM HEPES adjusted to pH 7.4 with NaOH. The bath solution (cytosolic surface of the patch) contained
134 mM KCl, 6 mM NaCl, 1.2 mM MgCl2, 5 mM EGTA, 11 mM glucose, 3 mM dipotassium ATP, and 10 mM HEPES (pH 7.4).
Depending on the experiment, the free Ca2+
concentration of the bath solution was changed from 0.3-10
µM by changing the Ca2+ concentration in the
corresponding solution. The appropriate amounts of CaCl2
were added, and the pH was adjusted according to a computer program on
the basis of the binding constants of Fabiato and checked by
fura 2 fluorescence (for details see Ref. 19). Experiments with
iberiotoxin (Latoxan, Rosans, France) were carried out on outside-out
patches, and bath and pipette solution were opposite to those used in
inside-out experiments. A multi-barreled perfusion pipette placed 200 µm away from the patch was used to switch the superfusion solution.
Electrophysiological experiments were performed at 20-22 °C, the
holding potential was 20 mV.
Conductance (G) values were calculated as G = I/Vm. Usually, each experiment was normalized by
dividing G values by Gmax, where
Gmax was defined as the largest G
value obtained in each experiment.
G/Gmax voltage curves were fitted
with a Boltzmann equation of the form
G/Gmax = (1 + exp((V1/2 Vm)/k]) 1 with the use of
Origin (version 6; Microcal Software, Northampton, MA). The data are
expressed as means ± S.E.
Protein Kinases and PKC Inhibitors--
Pure cGK I (26) or
the catalytic subunit of cAMP kinase (19) were prepared as described.
The cGK and cAK were applied to the membrane patches at a concentration
of 300 nM. The cGK was consistently used in the presence of
10 µM cGMP. The PKC inhibitor peptide
PKC19-31 was from Calbiochem and was applied at a
concentration of 5 µM. The non-peptide PKC inhibitor
Ro31-8220 was obtained from Biomol (Hamburg, Germany) and was used at
a concentration of 1 µM.
 |
RESULTS |
BK Channel Isoforms Cloned from Tracheal Smooth Muscle--
The BK
channels in native tracheal smooth muscle cells show diversity in
modulation by cGK and cAK (4, 19, 27). To analyze whether additional
yet unidentified mRNA transcripts code for BK channels that might
be specifically regulated by either cGK or cAK, we cloned BK channel
subunits from smooth muscle tissue of bovine trachea. In total,
nine full-length clones containing the M1 methionine (24) and
poly(A)+ tails of different length were isolated. In
general, the bovine BK channel primary structure is identical with that
from human (24, 28) with the exception of repetitive amino acid
sequences at the N terminus varying in length (Fig.
1A) and amino acids at
positions Thr139, Ser710, Ser711 of
the bovine sequence that are changed to Ala, Asn, Thr in the human
sequence, respectively. The nine clones obtained by cloning from
tracheal smooth muscle consisted of three populations differing only at
their C terminus (Fig. 1). Four clones of 6.1-6.6 kb were grouped into
class BKA. The BKA isoform has been identified
in a variety of species including human (24, 28). One clone of 4.4 kb
differed from the BKA clones in amino acids 1160-1166 at the C terminus and was classified as BKB. This clone
contained a 3'-untranslated region of 0.6 kb that was different from
the 3'-untranslated region of 3 kb from BKA. The
BKB-specific C terminus was recently also identified in rat
(GenBankTM U40603) and chicken (29). Another four clones
(BKC) of 3.3 kb were lacking the last 26 amino acids at the
C terminus of BKA. The C-terminal sequence
1137HSIP1140, which is common to all isoforms,
is followed by the sequence 1141PQT1143 in
BKC before the stop codon and the poly(A)+
tail. BKC does not contain a 3'-untranslated region, and
the poly(A) tail directly follows the stop codon. Since the analysis of
the genomic structure of the BK channel in rat (30) revealed a single
exon encoding the C-terminal part of the BKA isoform (amino
acids 1085-1166), the BKB and BKC isoforms may
be generated by alternative splicing at cryptic intron splice sites
within this exon. In fact, inspection of the nucleotide sequence at the junction sites reveals the presence of consensus motifs of intron 5'
donor splice sites (31) in BKA, namely GT at the junction of BKA to BKB (site 2 in Fig. 1B)
and AT at the junction of BKA to BKC (site 1 in
Fig. 1B). The consensus motifs GT and AT are conserved at
the respective splice site in mammalian BK channel nucleotide sequences
(Fig. 1B). Apart from BKB, additional C-terminal isoforms have been identified from others that probably result from
splicing at site 2 including Rat1BK, Rat2BK, and MouseBK (for details
see the legend of Fig. 1B). Thus, the GT and AT consensus motifs at sites 1 and 2 may serve as cryptic 5' donor splice sites within the C-terminal exon.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
A, BK channel isoforms cloned
from bovine tracheal smooth muscle. N-terminal alignment of the bovine
(BovBK) and human (HumBK) BK channel subunit
(24) and C-terminal alignment of the three isoforms BKA,
BKB, BKC identified in bovine tracheal smooth
muscle are shown. The amino acid sequence of BKB and
BKC different from that in BKA are
underlined and given in bold letters. Amino acid
numbers are given at the right margin. The phosphorylation site for
cGK, Ser1134, (16, 17), and the C-terminal consensus sites
Ser1151/Ser1154 for phosphorylation by PKC are
indicated in bold italics. B, alignment of
C-terminal nucleotide sequences of BKA, BKB,
BKC (BovBK) with BK channel isoforms from
different species, human BK (GenBankTM U11058), rat1 BK
(GenBankTM AF135265), mouse BK (GenBankTM
AF156674), and rat2 BK (GenBankTM U40603). The indicated
nucleotide sequence of bovine BKA and human BK is part of a
single exon encoding the C-terminal amino acids 1085-1166 (numbering
of BKA) (30). Splicing within this exon at the putative
cryptic intron site 1 starting with the consensus nucleotides GT or AT
(underlined) may result in the BKC-specific
C-terminal nucleotide sequence (indicated in bold letters).
Splicing at the putative cryptic intron site 2 starting with the
consensus site GT (underlined) may result in the
BKB-specific C-terminal nucleotide sequence (indicated in
bold letters). The BKB-specific C-terminal
sequence is also found in the rat2 BK. Further isoforms with specific C
termini (indicated in bold letters) such as the indicated
rat1 BK and mouse BK are probably also generated by splicing at site 2. Triplets represent the reading frame. Numbers of nucleotides are given
at the left and right margin of the alignments.
|
|
Basic Properties of BKCa Channels Expressed in HEK
Cells--
Membrane currents of nontransfected native HEK293 cells
were measured in inside-out patches. Depolarizing steps from a holding potential of 20 mV to positive potentials resulted in a small outward
current that showed no inactivation and exhibited no Ca2+
sensitivity. The steady-state current at +80 mV was 27.1 ± 2.5 pA
(n = 30). The amplitude of outward currents in HEK293
cells expressing BKA was considerably larger than in native
HEK cells. Mean current amplitude obtained under steady-state
conditions at +80 mV in cells expressing BKA was
1851.3 ± 176.0 pA (n = 34). Typical examples of
outward currents obtained from a native and a transfected cell are
shown in Fig. 2, A and
B. The results demonstrate that the outward current of
transfected cells was contaminated by an endogenous current component
by <2%. In some inside-out patches with low channel density, single
channel conductance was determined in the presence of symmetrically
high potassium of 140 mM. Channel openings could be
detected at membrane potentials from 60 mV to +80 mV (Fig.
2C shows an example from a cell transfected with
BKA). The current-voltage relations of the three C-terminal splice variants were linear in the voltage range between 60 and +60
mV and showed reversal potentials close to 0 mV (Fig. 2D). The mean unitary conductances were 276 ± 8.1 picosiemens
(BKA; n = 6), 260 ± 12.3 picosiemens
(BKB; n = 6), and 272 ± 16.3 picosiemens (BKC; n = 7). To further
determine the basic channel properties of the BKCa channel
isoforms, Ca2+ dependence was investigated in inside-out
patches. When the Ca2+ concentration was increased from 0.3 to 10 µM, a shift to the left of the normalized
conductance-voltage relations by 100 mV was observed (Fig.
3A). In eight patches from
clones BKA and BKB and in 10 patches from clone
BKC, the mean half-maximal activating voltage
(V1/2) was 100 ± 5, 95 ± 5, and
113 ± 9 mV in 0.3 µM Ca2+ and 2 ± 2.1, 0 ± 5.4, and 4 ± 8 mV in 10 µM
Ca2+-containing solution, respectively. There was a slight
increase of the slope factor between 0.3 and 1 µM
Ca2+ in all three isoforms, but no significant change was
observed between 1 µM (BKA 16.5 ± 1.9 mV, BKB 17.4 ± 1.8 mV, BKC 16.2 ± 2.0 mV) and 10 µM Ca2+ (BKA
18.8 ± 2.1 mV, BKB 20.3 ± 2.4 mV,
BKC 20.6 ± 2.1 mV). By plotting
V1/2 values obtained from the curves in Fig.
3A as a function of [Ca2+], a linear relation
was obtained with a reduction of V1/2 by 59 ± 6.7 (BKA), 55 ± 6.5 (BKB), and 68 ± 8.3 mV (BKC) per 10-fold increase of
[Ca2+] (Fig. 3B). The difference between the
V1/2 values was not statistically significant
(p > 0.1). To determine the sensitivity of the BK channel isoforms to the specific peptide blocker iberiotoxin, outside-out patches in the presence of 1 µM
[Ca2+]i were exposed to increasing concentrations
of the toxin (Fig. 3C). Mean half-maximal inhibitory
concentrations of iberiotoxin were 5.8 ± 0.7 nM
(BKA; n = 5), 5.7 ± 0.7 nM (BKB; n = 7), and 8.3 ± 2.0 nM (BKC; n = 7).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Characterization of BKCa channels
expressed in HEK293 cells. A and B,
representative currents from native- and BKA-transfected
HEK cells. Currents were recorded in the inside-out mode. The membrane
potential of the cells was held at 20 mV and then changed with a
series of 200-ms step pulses from 80 to +80 mV with 20-mV increments
at 5-s intervals. [Ca2+] in the bath solution was 1 µM. C, representative single channel
recordings from an inside-out patch at membrane potentials ranging from
60 to +80 mV; c indicates the closed state of the channel.
The patch was detached from a BKA-transfected HEK cell.
D, current-voltage relationships obtained from inside-out
patches detached from HEK cells transfected with BKA
(n = 6), BKB (n = 6), and
BKC (n = 7). Symbols represent
mean values. Single channel currents in C and D
were measured in symmetrical 140 mM KCl.
[Ca2+] in the bath solution was 1 µM.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 3.
Identical Ca2+ and iberiotoxin
sensitivities of BK channel isoforms expressed in HEK293 cells.
A, normalized conductance-voltage relations from inside-out
patches expressing BKA (n = 8),
BKB (n = 8), and BKC
(n = 10) isoforms. The values of membrane conductance
were first normalized to the maximal value and then averaged. Each
patch represents a different cell. Currents were evoked by applying a
200-ms depolarizing pulse every 5 s in 20-mV increments from a
holding potential of 20 mV to ± 160 mV. After each
current-voltage relation, [Ca2+] was raised stepwise from
0.3 to 10 µM. The curves represent the fits of
experimental points to the Boltzmann equation. B, plot of
the voltage required for half-maximal channel activation
(V1/2) as a function of [Ca2+]
(same data as in A). Straight lines are calculated from
linear regression (r = 0.96 to 0.99). C,
concentration-dependent inhibition of the BK channel
current (IKCa) by iberiotoxin (IbTX)
in outside-out patches. Currents were evoked by voltage steps of 200 ms
from 20 to +40 mV. Means ± S.E. of five patches from
BKA and of seven patches from BKB and
BKC, respectively, are shown. [Ca2+] was 1 µM.
|
|
Regulation of C-terminal Splice Variants by cGK and cAK--
The
activity of BK channels is modulated in native cells by cAK and cGK. To
investigate whether the C-terminal splice variants expressed in HEK293
cells are also regulated by the kinases, either the catalytic subunit
of cAK or cGK plus cGMP were applied to the cytosolic face of excised
inside-out membrane patches (Fig. 4). In
the presence of cGK (upper panels), a 26- and 31-mV shift to
the left of the normalized conductance-voltage relation was observed in
splice variants BKA (V1/2 before,
57.9 ± 5.9 mV; V1/2 after, cGK 32.2 ± 3.5 mV; n = 7) and BKB
(V1/2 before, 54.8 ± 6.1 mV;
V1/2 after, cGK 24.1 ± 2.8 mV;
n = 8). Membrane conductance of splice variant
BKC, however, did not respond significantly to cGK,
V1/2 was 54.5 ± 5.8 mV before and
47.5 ± 5.1 mV after application of the kinase. Opposite to cGK,
cAK (lower panels) had no significant influence on
BKA (V1/2 before, 46.2 ± 5.3 mV; V1/2 after, cAK 43.7 ± 4.8 mV;
n = 8) and BKB (V1/2
before, 51.0 ± 5.6 mV; V1/2 after, cAK
49.4 ± 5.1 mV; n = 8) but induced a 35-mV shift
to the left of the normalized conductance-voltage relation obtained
from BKC (V1/2 before, 62.3 ± 6.9 mV; V1/2 after, cAK 27.8 ± 3.1 mV;
n = 6). The results of Fig. 4 suggest that the
C-terminal amino acids determine whether the channel is responsive to
cGK or cAK.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 4.
Regulation of BK channel isoforms expressed
in HEK293 cells by cGK and cAK. Normalized conductance-voltage
relations from inside-out patches in the absence and presence of cGK
(upper panels) and cAK (lower panels). cGK shifts
the curve to the left in patches expressing BKA
(n = 7) and BKB (n = 8) but
not in those expressing BKC (n = 8). Cyclic
AK has no effect on patches expressing BKA
(n = 8) and BKB (n = 8) but
induced a left-shift of the curve obtained with BKC
(n = 6). Each patch represents a different cell.
Currents were evoked by applying a 200-ms depolarizing pulse every
5 s in 20-mV increments from a holding potential of 20 mV
to ± 120 mV. The data were fitted by a Boltzmann equation. The
insets show representative BK current recordings elicited by
200 ms pulses from 20 to +40 mV. Closed symbols represent
currents in the presence of either cGK or cAK; [Ca2+] in
the bath solution was 1 µM. Cells from the same
transfection were used for testing BK channel conductance in the
absence and presence of the respective kinase as
V1/2 values slightly varied between different
rounds of transfection.
|
|
Effects of cGK and cAK after Mutation of the Putative PKC Sites
Ser1151 and Ser1154--
Inspection of the C
terminus revealed the tandem motif
RXKS1151RXS1154RXK
(32) for phosphorylation by PKC, which was present in BKA and BKB but not in isoform BKC (Fig.
1A). To study the possible influence of this site on the
channel regulation by cGK and cAK, a mutant BKA was created
in which Ser1151 and Ser1154 were replaced by
alanine (S1151A/S1154A). Inside-out patches excised from HEK293 cells
expressing the double mutant construct proved insensitive to
stimulation by cGK but became responsive to cAK, similar as the
BKC isoform with its truncated C terminus (Fig.
5A).
V1/2 obtained from conductance-voltage relations
was 53.6 ± 6.2 mV before (control) and 49.7 ± 5.4 mV after
the application of cGK (n = 8; not significant). In
contrast, cAK shifted V1/2 by 31 mV from
40.6 ± 4.3 to 9.7 ± 1.3 mV (n = 12). These
results indicate that the intact putative tandem PKC motif is a
prerequisite for the channel to become regulated by cGK. To evaluate
whether cAK stimulated the activity of the mutant BKA
isoform by phosphorylation of Ser1134, the site
phosphorylated by cGK (16, 17), this serine was changed to alanine. As
expected, the single mutation S1134A in BKA resulted in
loss of stimulation of channel activity by cGK (Fig. 5B).
The inability of cAK to activate wild-type BKA channels was
unaffected by mutation S1134A (Fig. 5B), demonstrating that the mutation of the tandem PKC site in BKA was responsible
for the specific activation by cAK. Mean V1/2
values in Fig. 5B were 58.9 ± 6.1 mV (control) and
60 ± 6.3 mV (cGK; n = 6) and 48.9 ± 5.3 mV
(control) and 51.0 ± 5.5 mV (cAK: n = 8). When
the double mutation in BKA S1151A/S1154A was combined with
the mutation S1134A, a channel was created that failed to respond to
cGK (not shown) but was activated by cAK, indicating that cAK
phosphorylates a different site of the BK channel than cGK (Fig.
5C). Cyclic AK produced a shift to the left by 30 mV; the
mean V1/2 values were 55.8 ± 5.9 mV before
and 25.4 ± 3.2 mV (n = 10) in the presence of
cAK. Similarly, mutation of the cGK site S1134A in splice variant BKC had no influence on the stimulatory action of cAK;
V1/2 was shifted to the left by 34 mV from
45.4 ± 5.2 mV (control) to 1.7 ± 2.2 mV in the presence of
cAK (n = 6; data not shown). Since phosphorylation of
Ser869 of the human BK channel has been suggested to
account for the stimulatory effect of cAK (15); the corresponding
Ser922 of the bovine BKA channel was mutated to
alanine in addition to the S1151A/S1154A exchange. The cAK-mediated
increase in BK channel activity was completely eliminated in patches
from HEK cells expressing this S922A mutant (Fig. 5C). The
mean V1/2 values were 52.0 ± 5.4 mV before
and 51.0 ± 5.5 mV (n = 13) in the presence of
cAK. This finding confirms that cAK and cGK stimulate BK channel activity by phosphorylating different sites of the BK channel subunit, i.e. Ser922 and Ser1134,
respectively.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 5.
Activation of the BKA isoform by
cGK requires the putative PKC phosphorylation sites Ser1151
and Ser1154. Normalized conductance-voltage relations
from inside-out patches excised from HEK293 cells expressing
BKA. A, mutation of the tandem PKC site,
S1151A/S1154A, switches channel activation from cGK (n = 8) to cAK (n = 12). B, mutation of the
putative cGK site, S1134A, abolishes the cGK effect (n = 6), whereas cAK remains ineffective (n = 8).
C, left, combined mutations S1151A/S1154A and
S1134A do not affect the shift to the left of the curve by cAK
(n = 10). C, right, combined
mutations S1151A/S1154A and S922A prevent channel stimulation by cAK.
A-C, each patch was from a different cell. Currents were
evoked by applying a 200-ms depolarizing pulse every 5 s in 20-mV
increments from a holding potential of 20 mV to ± 120 mV. The
insets show representative BK current recordings
elicited by 200-ms pulses from 20 to +40 mV. Closed
symbols represent currents in the presence of cGK or cAK;
[Ca2+] in the bath solution was 1 µM.
ctr, control.
|
|
In summary, these results suggest that an intrinsic PKC activity of
HEK293 cells phosphorylates the BKA and BKB
isoforms and consequently allows channel stimulation by cGK. The
absence of the PKC consensus motif in the BKC isoform leads
to exclusive channel stimulation by cAK. Further in depth analysis
revealed that phosphorylation of both serines were involved in the
activation switch, because mutation of either Ser1151 or
Ser1154 alone led to an intermediate phenotype with respect
to channel activation by cGK and cAK (data not shown).
Inhibition of PKC Switches BK Channel Activation from cGK to
cAK--
To provide additional evidence for the involvement of PKC in
the regulation of the BK channel, inside-out patches expressing the
BKA isoform were superfused with the inhibitory peptide of PKC (PKC19-31) or the PKC inhibitor Ro31-8220. To allow
complete dephosphorylation of the PKC sites, inside-out patches were
first superfused for 5 min with ATP-free solution to which either
PKC19-31 (Fig.
6A) or Ro31-8220 (Fig.
6B) had been added. This solution was then changed to a
solution containing ATP, PKC19-31, or Ro31-8220 and
either cGK or cAK. Similarly to the results obtained with the PKC
mutation S1151A/S1154A, PKC19-31, and Ro31-8220 prevented
the stimulatory action of cGK on BKA and switched the
responsiveness of the channel toward cAK. V1/2 values obtained from conductance-voltage relations in the presence of
PKC19-31 (Fig. 6A) were not significantly
changed by cGK (before, 55.0 ± 5.9 mV; after cGK, 49.3 ± 5.7 mV; n = 7), whereas a shift to the left by 28 mV
was produced by cAK (before 48.8 ± 5.3 mV; after cAK 20.3 ± 2.5 mV; n = 7). Similar results were obtained with Ro31-8220 (Fig. 6B); the mean V1/2
values before (57.4 ± 6.3 mV) and after cGK (52.5 ± 6.1 mV;
n = 8) were not significantly different, whereas cAK
produced a shift to the left by 31 mV (before 54.5 ± 5.7 mV;
after cAK 23.0 ± 2.9 mV; n = 8). The results
demonstrate that inhibition of PKC, apparently associated with the BK
channel in the excised patch, switches stimulation of channel activity from cGK to cAK.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Inhibition of PKC switches stimulation of BK
channel activity from cGK to cAK. Normalized conductance-voltage
relations from inside-out patches excised from HEK293 cells expressing
the BKA isoform. Patches were superfused with ATP-free
solution plus 5 µM PKC19-31 (A)
or 1 µM Ro31-8220 (B) for 5 min first (not
shown) and then with a solution containing 3 mM ATP, 5 µM PKC19-31, or 1 µM
Ro-31-8220 and either cGK (left panels in A
(n = 7) and B (n = 8) or cAK
(right panels in A (n = 7) and
B (n = 8). Note that only cAK increased
membrane conductance and shifted the curve significantly to the left.
Every patch was obtained from a different cell. Currents were elicited
by applying a 200-ms depolarizing pulse every 5 s in 20-mV
increments from a holding potential of 20 mV to ± 120 mV. The
insets show representative BK current recordings elicited by
200-ms pulses from 20 to +40 mV. [Ca2+] in the bath
solution was 1 µM. ctr, control.
|
|
 |
DISCUSSION |
The Ca2+-activated K+ channel of the BK
type is subject to regulation by both the cAMP and the cGMP signaling
pathway. Its contribution to smooth muscle relaxation has recently been
demonstrated by gene deletion of the Ca2+
sensitivity-enhancing 1 subunit that resulted in
hypertension of gene-targeted mice (33, 34). Moreover, blockade of BK
channels can interfere with the relaxation-promoting effect from
NO/cGMP (35, 36). Stimulation of BK channels by cyclic
nucleotide-dependent protein kinases was attributed to the
phosphorylation of the subunit at sites specific for either cAK
(15, 23) or cGK (16, 17). Although these reports suggested the
existence of specific phosphorylation sites that are conserved in
mammalian BK channels, they do not explain the diversity of channel
regulation by cAK (4, 5, 37, 38) and cGK (2, 18, 19) found in native cells. Further requirements are apparently needed to allow specific channel stimulation by either of these kinases. The objective of this
study was therefore to address the question of whether alternative exon
splicing of the subunit and/or additional determinants are
responsible for specific enhancement of channel activity by cAK and
cGK. We identified three full-length splice variants in tracheal smooth
muscle differing only at their C terminus. In contrast to BK channel
isoforms identified recently (39), the single channel conductance,
Ca2+, voltage, and iberiotoxin sensitivity of the isoforms
BKA, BKB, and BKC, were nearly
identical (Figs. 2 and 3). The unexpected finding that BKA
and BKB were exclusively stimulated by cGK, whereas BKC was stimulated only by cAK, prompted us to search for
the determining factor. We identified a tandem PKC motif close to the C
terminus that is present in BKA and BKB but not
in BKC. The residues Ser1151 and
Ser1154 of this motif have an optimal consensus sequence
for PKC-dependent phosphorylation (32). Our results
strongly suggest that these sites are an effective PKC substrate for
the following reasons. (i) PKC inhibition by two different inhibitors
switched the specificity of channel stimulation from cGK toward cAK
(Fig. 6). Since PKC was inhibited in the inside-out configuration, we
suppose that the PKC remains functionally associated with the channel
in the detached patch, similar to that suggested recently (40). (ii) Cyclic GK fails to stimulate channel activity when
PKC-dependent phosphorylation of the C terminus is
prevented due to mutation of both Ser1151 and
Ser1154 (Fig. 5). Mutation of either Ser1151 or
Ser1154 alone yielded only an intermediate phenotype with
respect to channel stimulation by cAK and cGK.
The channel activity in inside-out patches from HEK293 cells expressing
BKA or BKB is per se stimulated by
cGK (Fig. 4). This suggests that phosphorylation of the tandem motif by
PKC occurs constitutively. A constitutive or unconditional
phosphorylation possibly mediated by PKC has recently been suggested
for BK channels in GH4C1 cells (41). Due to the
phosphorylation at the tandem motif, the switch of channel regulation
from cGK to cAK in the presence of PKC inhibitors may involve the
activity of a phosphatase that dephosphorylates the channel at the PKC
motif before the channel becomes responsive to cAK (Fig. 6). Regulation
of BK channels by a closely associated phosphatase has been shown in
neuronal (40) and smooth muscle cells (19, 37). The present study also
clearly demonstrates that cGK and cAK phosphorylate different sites of
the channel. In agreement with Alioua et al. (16) and Fukao
et al. (17), Ser1134 was identified as target
for cGK-dependent phosphorylation. In contrast to cGK, cAK
does not phosphorylate Ser1134. Cyclic AK enhances channel
activity by phosphorylating Ser922, a result that confirms
recent findings (13, 15). The phosphorylation of an additional cAK site
introduced by a facultative STREX exon was shown to inhibit BK channel
activity (13). Hence, the lack of cAK to stimulate BKA and
BKB channels that do not contain the STREX exon could be
due to an inhibitory effect mediated by phosphorylation of the tandem
PKC site.
Cyclic AK was demonstrated to bind to the large C-terminal part of the
BK channel from Drosophila (21) and to coimmunoprecipitate with a mouse brain BK channel expressed in HEK293 cells (13). We
speculated, therefore, whether phosphorylation of the tandem PKC site
is necessary for binding of cGK to the channel. Since BKC
with its truncated C terminus is unresponsive to cGK, we tested a
phosphopeptide comprising the last 26 amino acids of the
BKA channel including the phosphorylated
Ser1151 and Ser1154 for competition with cGK.
This phosphopeptide was not able to attenuate the stimulatory effect of
cGK,2 thus making it unlikely
that cGK directly interacts with the phosphorylated C-terminal portion
of the channel. Contrary to our findings with the BKA and
BKB channel from bovine tracheal smooth muscle, a specific
BK channel isoform from mouse brain is regulated by cAK when expressed
in HEK293 cells (13). Comparison of the respective primary structures
reveals that this BK channel from mouse brain (14) has an extended C
terminus starting downstream of the PKC tandem motif, suggesting that
an altered C terminus may affect phosphorylation by PKC. Preferential
activation of BK channels by cAK may be achieved by specific splice
variants like the BKC isoform, lacking the C-terminal tail
including the tandem motif for PKC (Fig.
7). Previous studies confirmed the presence of mRNA transcripts in the range of 4 kb in smooth muscle tissue (28). These mRNA species may represent BK channels similar to the BKB and BKC isoform cloned from tracheal
smooth muscle in this study. Intriguingly, the BKB and
BKC isoforms result from splicing at cryptic intron sites
within the C-terminal exon. This processing of the pre-mRNA might
occur in a tissue-specific manner and further adds complexity to the
functional role of splice variants.

View larger version (56K):
[in this window]
[in a new window]
|
Fig. 7.
Scheme illustrating the role of BK channel
isoforms in cAMP- and cGMP-mediated smooth muscle relaxation. The
observation that PKC inhibits BK channels in smooth muscle (44)
suggests that phosphorylation of the BK channel by PKC supports the
contractile response of hormones coupling to the diacylglycerol
(AC)/PKC and inositol 1,4,5-trisphosphate
(IP3) pathway. In turn, phosphorylation of
the tandem motif by PKC promotes the counter-regulatory effect of the
NO/cGMP/cGK cascade, since phosphorylation by PKC is a prerequisite for
cGK to become an effective activator of BKA and
BKB channel isoforms. Dephosphorylation of the tandem PKC
motif mediated by a phosphatase or expression of isoforms like
BKC lacking the C-terminal tandem PKC site allow BK channel
activation by cAK.
|
|
In smooth muscle, the BK channel is a multimeric macrocomplex
consisting of four and four 1 subunits (42). The
co-expression of the 1 subunit may affect the molecular
mechanisms of channel regulation identified here. However, a previous
report studying channel regulation by cAK clearly demonstrated that
enhancement of channel activity was not altered when the subunit
was co-expressed (15). In addition to auxiliary subunits, the
interaction of protein kinases with BK channels may be influenced by
the host cell. When choosing Chinese hamster ovary cells as hosts, both cAK and cGK failed to stimulate BK channels (43). In the latter report,
the transfected human BK channel starts translation from methionine
M3 (24). The difference in the present study cannot be
explained by the start methionine, since the human BK channel with
M3 as translational start was similarly activated by cGK when expressed in HEK293 cells as the bovine BKA isoform
with M1 as the translational start.2 This
finding suggests that a specific membrane environment and/or putative
scaffold and signaling proteins of host cells are needed for the
functional interaction of kinases and channel isoforms. In conclusion,
the results of this study establish a complex link between PKC and the
ability of cGK and cAK to regulate BK channels that contain typical C
termini like BKA and BKB. We show for the first
time that phosphorylation by PKC controls the activation of the channel
by cGK. This demonstration is a further step in our understanding of
the diversity and complexity of BK channel regulation. The findings may
be particularly significant for mechanisms of smooth muscle relaxation
and may explain specific channel regulation in native cells by either
cAMP or cGMP pathways.
 |
ACKNOWLEDGEMENTS |
We thank Tina Ruttkowski for excellent
technical assistance and Dr. Franz Hofmann for helpful review.
 |
FOOTNOTES |
*
This work was supported by Deutsche Forschungsgemeinschaft.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) AY033472 (BKA), AY033473
(BKB), and AY033474 (BKC).
To whom correspondence should be addressed. Tel.:
49-7071-2976781; Fax: 49-7071-292476; E-mail:
peter.ruth@uni-tuebingen.de.
¶
Contributed equally.
Published, JBC Papers in Press, August 20, 2001, DOI 10.1074/jbc.M104202200
2
X.-B. Zhou et al., unpublished results.
 |
ABBREVIATIONS |
The abbreviations used are:
cGK, cGMP kinase;
cAK, cAMP kinase;
PKC, protein kinase C;
kb, kilobase.
 |
REFERENCES |
| 1.
|
Pfeifer, A.,
Ruth, P.,
Dostmann, W.,
Sausbier, M.,
Klatt, P.,
and Hofmann, F.
(1999)
Rev. Physiol. Biochem. Pharmacol.
135,
105-149[Medline]
[Order article via Infotrieve]
|
| 2.
|
Robertson, B. E,
Schubert, R.,
Hescheler, J.,
and Nelson, M. T.
(1993)
Am. J. Physiol.
265,
C299-C303[Abstract/Free Full Text]
|
| 3.
|
Stockand, J. D.,
and Sansom, S. C.
(1996)
Am. J. Physiol.
271,
C1669-C1677[Abstract/Free Full Text]
|
| 4.
|
Kume, H.,
Takai, A.,
Tokuno, H.,
and Tomita, T.
(1989)
Nature
341,
152-154[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Kume, H.,
Hall, I. P.,
Washabau, R. J.,
Takagi, K.,
and Kotlikoff, M. I.
(1994)
J. Clin. Invest.
93,
371-379
|
| 6.
|
Nelson, M. T.,
and Quayle, J. M.
(1995)
Am. J. Physiol.
268,
C799-C822[Abstract/Free Full Text]
|
| 7.
|
Levitan, I. B.
(1994)
Annu. Rev. Physiol.
56,
193-212[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Shipston, M. J.,
Kelly, J. S.,
and Antoni, F. A.
(1996)
J. Biol. Chem.
271,
9197-9200[Abstract/Free Full Text]
|
| 9.
|
Lee, K.,
Rowe, I. C.,
and Ashford, M. L.
(1995)
J. Physiol. (Lond.)
488,
319-337[Abstract/Free Full Text]
|
| 10.
|
White, R. E.,
Schonbrunn, A.,
and Armstrong, D. L.
(1991)
Nature
351,
570-573[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Perez, G.,
and Toro, L.
(1994)
Am. J. Physiol.
266,
C1459-C1463[Abstract/Free Full Text]
|
| 12.
|
Zhou, X.-B.,
Wang, G.-X.,
Ruth, P.,
Huneke, B.,
and Korth, M.
(2000)
Am. J. Physiol. Cell Physiol.
279,
C1751-1759[Abstract/Free Full Text]
|
| 13.
|
Tian, L.,
Duncan, R. R.,
Hammond, M. S.,
Coghill, L. S.,
Wen, H.,
Rusinova, R.,
Clark, A. G.,
Levitan, I. B.,
and Shipston, M. J.
(2001)
J. Biol. Chem.
276,
7717-7720[Abstract/Free Full Text]
|
| 14.
|
Butler, A.,
Tsunoda, S.,
McCobb, D. P.,
Wei, A.,
and Salkoff, L.
(1993)
Science
261,
221-224[Abstract/Free Full Text]
|
| 15.
|
Nara, M.,
Dhulipala, P. D.,
Wang, Y. X.,
and Kotlikoff, M. I.
(1998)
J. Biol. Chem.
273,
14920-14924[Abstract/Free Full Text]
|
| 16.
|
Alioua, A.,
Tanaka, Y.,
Wallner, M.,
Hofmann, F.,
Ruth, P.,
Meera, P.,
and Toro, L.
(1998)
J. Biol. Chem.
273,
32950-32956[Abstract/Free Full Text]
|
| 17.
|
Fukao, M.,
Mason, H. S.,
Britton, F. C.,
Kenyon, J. L.,
Horowitz, B.,
and Keef, K. D.
(1999)
J. Biol. Chem.
274,
10927-10935[Abstract/Free Full Text]
|
| 18.
|
White, R. E.,
Lee, A. B.,
Shcherbatko, A. D.,
Lincoln, T. M.,
Schonbrunn, A.,
and Armstrong, D. L.
(1993)
Nature
361,
263-266[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Zhou, X.-B.,
Ruth, P.,
Schlossmann, J.,
Hofmann, F.,
and Korth, M.
(1996)
J. Biol. Chem.
271,
19760-19767[Abstract/Free Full Text]
|
| 20.
|
Schubert, R.,
Serebryakov, V. N.,
Engel, H.,
and Hopp, H. H.
(1996)
Am. J. Physiol.
271,
C1203-C1211[Abstract/Free Full Text]
|
| 21.
|
Wang, J.,
Zhou, Y.,
Wen, H.,
and Levitan, I. B.
(1999)
J. Neurosci.
19,
RC4[Abstract/Free Full Text]
|
| 22.
|
Shipston, M. J.,
and Armstrong, D. L.
(1996)
J. Physiol. (Lond.)
493,
665-672[Abstract/Free Full Text]
|
| 23.
|
Esguerra, M.,
Wang, J.,
Foster, C. D.,
Adelman, J. P.,
North, R. A.,
and Levitan, I. B.
(1994)
Nature
369,
563-565[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Wallner, M.,
Meera, P.,
Ottolia, M.,
Kaczorowski, G. J.,
Latorre, R.,
Garcia, M. L.,
Stefani, E.,
and Toro, L.
(1995)
Receptors Channels
3,
185-199[Medline]
[Order article via Infotrieve]
|
| 25.
|
Hamill, O. P.,
Marty, A.,
Neher, E.,
Sakmann, B.,
and Sigworth, F. J.
(1981)
Pfluegers Arch.
391,
85-100[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Ruth, P.,
Pfeifer, A.,
Kamm, S.,
Klatt, P.,
Dostmann, W. R.,
and Hofmann, F.
(1997)
J. Biol. Chem.
272,
10522-10528[Abstract/Free Full Text]
|
| 27.
|
Hiramatsu, T.,
Kume, H.,
Kotlikoff, M. I.,
and Takagi, K.
(1994)
Clin. Exp. Pharmacol. Physiol.
21,
367-375[Medline]
[Order article via Infotrieve]
|
| 28.
|
Tseng-Crank, J.,
Foster, C. D.,
Krause, J. D.,
Mertz, R.,
Godinot, N.,
DiChiara, T. J.,
and Reinhart, P. H.
(1994)
Neuron
13,
1315-1330[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Navaratnam, D. S.,
Bell, T. J.,
Tu, T. D.,
Cohen, E. L.,
and Oberholtzer, J. C.
(1997)
Neuron
19,
1077-1085[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Huelsemann, S.
(1999)
Cloning and Characterization of a Gene Coding for Ca2+-activated K+ channel.Doctoral dissertation
, Cuvillier Verlag Göttingen
|
| 31.
|
Dietrich, R. C.,
Incorvaia, R.,
and Padgett, R. A.
(1997)
Mol. Cell
1,
151-160[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Kennelly, P. J.,
and Krebs, E. G.
(1991)
J. Biol. Chem.
266,
15555-15558[Free Full Text]
|
| 33.
|
Brenner, R.,
Perez, G. J.,
Bonev, A. D.,
Eckman, D. M.,
Kosek, J. C.,
Wiler, S. W.,
Patterson, A. J.,
Nelson, M. T.,
and Aldrich, R. W.
(2000)
Nature
407,
870-876[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Plüger, S.,
Faulhaber, J.,
Furstenau, M.,
Lohn, M.,
Waldschutz, R.,
Gollasch, M.,
Haller, H.,
Luft, F. C.,
Ehmke, H.,
and Pongs, O.
(2000)
Circ. Res.
87,
53-60
|
| 35.
|
Bialecki, R. A.,
and Stinson-Fisher, C.
(1995)
Am. J. Physiol.
268,
L152-L159[Abstract/Free Full Text]
|
| 36.
|
Sausbier, M.,
Schubert, R.,
Voigt, V.,
Hirneiss, C.,
Pfeifer, A.,
Korth, M.,
Kleppisch, T.,
Ruth, P.,
and Hofmann, F.
(2000)
Circ. Res.
87,
825-830[Abstract/Free Full Text]
|
| 37.
|
Carl, A.,
Kenyon, J. L.,
Uemura, D.,
Fusetani, N.,
and Sanders, K. M.
(1991)
Am. J. Physiol.
261,
C387-C392[Abstract/Free Full Text]
|
| 38.
|
Meera, P.,
Anwer, K.,
Monga, M.,
Oberti, C.,
Stefani, E.,
Toro, L.,
and Sanborn, B. M.
(1995)
Am. J. Physiol.
269,
C312-C317[Abstract/Free Full Text]
|
| 39.
|
Benkusky, N. A.,
Fergus, D. J.,
Zucchero, T. M.,
and England, S. K.
(2000)
J. Biol. Chem.
275,
27712-27719[Abstract/Free Full Text]
|
| 40.
|
Reinhart, P. H.,
and Levitan, I. B.
(1995)
J. Neurosci.
15,
4572-4579[Abstract]
|
| 41.
|
Hall, S. K.,
and Armstrong, D. L.
(2000)
J. Biol. Chem.
275,
3749-3754[Abstract/Free Full Text]
|
| 42.
|
Knaus, H. G.,
Folander, K.,
Garcia-Calvo, M.,
Garcia, M. L.,
Kaczorowski, G. J.,
Smith, M.,
and Swanson, R.
(1994)
J. Biol. Chem.
269,
17274-17278[Abstract/Free Full Text]
|
| 43.
|
Zhou, X.-B.,
Schlossmann, J.,
Hofmann, F.,
Ruth, P.,
and Korth, M.
(1998)
Pfluegers Arch.
436,
725-734[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Schubert, R.,
Noack, T.,
and Serebryakov, V. N.
(1999)
Am. J. Physiol.
276,
C648-C658[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Simon, E. O. Harrington, G. X. Liu, G. Koren, and G. Choudhary
Mechanism of C-type natriuretic peptide-induced endothelial cell hyperpolarization
Am J Physiol Lung Cell Mol Physiol,
February 1, 2009;
296(2):
L248 - L256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Godlewski, L. Offertaler, D. Osei-Hyiaman, F. M. Mo, J. Harvey-White, J. Liu, M. I. Davis, L. Zhang, R. K. Razdan, G. Milman, et al.
The Endogenous Brain Constituent N-Arachidonoyl L-Serine Is an Activator of Large Conductance Ca2+-Activated K+ Channels
J. Pharmacol. Exp. Ther.,
January 1, 2009;
328(1):
351 - 361.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tian, O. Jeffries, H. McClafferty, A. Molyvdas, I. C. M. Rowe, F. Saleem, L. Chen, J. Greaves, L. H. Chamberlain, H.-G. Knaus, et al.
Palmitoylation gates phosphorylation-dependent regulation of BK potassium channels
PNAS,
December 30, 2008;
105(52):
21006 - 21011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Estilo, W. Liu, N. Pastor-Soler, P. Mitchell, M. D. Carattino, T. R. Kleyman, and L. M. Satlin
Effect of aldosterone on BK channel expression in mammalian cortical collecting duct
Am J Physiol Renal Physiol,
September 1, 2008;
295(3):
F780 - F788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X.-B. Zhou, I. Wulfsen, S. Lutz, E. Utku, U. Sausbier, P. Ruth, T. Wieland, and M. Korth
M2 Muscarinic Receptors Induce Airway Smooth Muscle Activation via a Dual, G{beta}{gamma}-mediated Inhibition of Large Conductance Ca2+-activated K+ Channel Activity
J. Biol. Chem.,
July 25, 2008;
283(30):
21036 - 21044.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. F. King and A. Townsend-Nicholson
Involvement of P2Y1 and P2Y11 Purinoceptors in Parasympathetic Inhibition of Colonic Smooth Muscle
J. Pharmacol. Exp. Ther.,
March 1, 2008;
324(3):
1055 - 1063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tian, H. McClafferty, L. Chen, and M. J. Shipston
Reversible Tyrosine Protein Phosphorylation Regulates Large Conductance Voltage- and Calcium-activated Potassium Channels via Cortactin
J. Biol. Chem.,
February 8, 2008;
283(6):
3067 - 3076.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Sanderson, P. Delmotte, Y. Bai, and J. F. Perez-Zogbhi
Regulation of Airway Smooth Muscle Cell Contractility by Ca2+ Signaling and Sensitivity
Proceedings of the ATS,
January 1, 2008;
5(1):
23 - 31.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Zhang, H. H. Patel, F. Murray, C. V. Remillard, C. Schach, P. A. Thistlethwaite, Paul. A. Insel, and J. X.-J. Yuan
Pulmonary artery smooth muscle cells from normal subjects and IPAH patients show divergent cAMP-mediated effects on TRPC expression and capacitative Ca2+ entry
Am J Physiol Lung Cell Mol Physiol,
May 1, 2007;
292(5):
L1202 - L1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. K. Isacson, Q. Lu, R. H. Karas, and D. H. Cox
RACK1 is a BKCa channel binding protein
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1459 - C1466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Magnusson, C. M. Sorensen, T. H. Braunstein, N.-H. Holstein-Rathlou, and M. Salomonsson
Renovascular BKCa channels are not activated in vivo under resting conditions and during agonist stimulation
Am J Physiol Regulatory Integrative Comp Physiol,
January 1, 2007;
292(1):
R345 - R353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Giembycz and R. Newton
Beyond the dogma: novel {beta}2-adrenoceptor signalling in the airways.
Eur. Respir. J.,
June 1, 2006;
27(6):
1286 - 1306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. F. Stowe, M. Aldakkak, A. K. S. Camara, M. L. Riess, A. Heinen, S. G. Varadarajan, and M.-T. Jiang
Cardiac mitochondrial preconditioning by Big Ca2+-sensitive K+ channel opening requires superoxide radical generation
Am J Physiol Heart Circ Physiol,
January 1, 2006;
290(1):
H434 - H440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zhou, L. Liu, and D. Hu
Involvement of BKCa {alpha} subunit tyrosine phosphorylation in vascular hyporesponsiveness of superior mesenteric artery following hemorrhagic shock in rats
Cardiovasc Res,
November 1, 2005;
68(2):
327 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Chen, L. Tian, S. H.-F. MacDonald, H. McClafferty, M. S. L. Hammond, J.-M. Huibant, P. Ruth, H.-G. Knaus, and M. J. Shipston
Functionally Diverse Complement of Large Conductance Calcium- and Voltage-activated Potassium Channel (BK) {alpha}-Subunits Generated from a Single Site of Splicing
J. Biol. Chem.,
September 30, 2005;
280(39):
33599 - 33609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Yang, J. W. Clark, R. M. Bryan, and C. S. Robertson
Mathematical modeling of the nitric oxide/cGMP pathway in the vascular smooth muscle cell
Am J Physiol Heart Circ Physiol,
August 1, 2005;
289(2):
H886 - H897.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sausbier, C. Arntz, I. Bucurenciu, H. Zhao, X.-B. Zhou, U. Sausbier, S. Feil, S. Kamm, K. Essin, C. A. Sailer, et al.
Elevated Blood Pressure Linked to Primary Hyperaldosteronism and Impaired Vasodilation in BK Channel-Deficient Mice
Circulation,
July 5, 2005;
112(1):
60 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Brainard, A. J. Miller, J. R. Martens, and S. K. England
Maxi-K channels localize to caveolae in human myometrium: a role for an actin-channel-caveolin complex in the regulation of myometrial smooth muscle K+ current
Am J Physiol Cell Physiol,
July 1, 2005;
289(1):
C49 - C57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Tian, L. S. Coghill, H. McClafferty, S. H.-F. MacDonald, F. A. Antoni, P. Ruth, H.-G. Knaus, and M. J. Shipston
Distinct stoichiometry of BKCa channel tetramer phosphorylation specifies channel activation and inhibition by cAMP-dependent protein kinase
PNAS,
August 10, 2004;
101(32):
11897 - 11902.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Snellman and S. Nawy
cGMP-Dependent Kinase Regulates Response Sensitivity of the Mouse On Bipolar Cell
J. Neurosci.,
July 21, 2004;
24(29):
6621 - 6628.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. R. Wolfram Kuhlmann, C. Gast, F. Li, M. Schafer, H. Tillmanns, B. Waldecker, and J. Wiecha
Cerivastatin Activates Endothelial Calcium-Activated Potassium Channels and Thereby Modulates Endothelial Nitric Oxide Production and Cell Proliferation
J. Am. Soc. Nephrol.,
April 1, 2004;
15(4):
868 - 875.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. A Widmer, I. C M Rowe, and M. J Shipston
Conditional protein phosphorylation regulates BK channel activity in rat cerebellar Purkinje neurons
J. Physiol.,
October 15, 2003;
552(2):
379 - 391.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Steffens, X.-B. Zhou, U. Sausbier, C. Sailer, K. Motejlek, P. Ruth, J. Olcese, M. Korth, and T. Wieland
Melatonin Receptor Signaling in Pregnant and Nonpregnant Rat Uterine Myocytes as Probed by Large Conductance Ca2+-Activated K+ Channel Activity
Mol. Endocrinol.,
October 1, 2003;
17(10):
2103 - 2115.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Erxleben, A. L. Everhart, C. Romeo, H. Florance, M. B. Bauer, D. A. Alcorta, S. Rossie, M. J. Shipston, and D. L. Armstrong
Interacting Effects of N-terminal Variation and Strex Exon Splicing on slo Potassium Channel Regulation by Calcium, Phosphorylation, and Oxidation
J. Biol. Chem.,
July 19, 2002;
277(30):
27045 - 27052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fury, S. O. Marx, and A. R. Marks
Molecular BKology: The Study of Splicing and Dicing
Sci. Signal.,
March 12, 2002;
2002(123):
pe12 - pe12.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|